US 8338412
Inhibitors of P38
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8338412 (Inhibitors of P38) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/18, A61P11/00